Audience Discussion: Planning for the Patent Lifecycle to Anticipate Exclusivity Gaps & Assess the Relevance of the Patent Cliff

Time: 2:35 pm
day: Day One

Details:

  • Share how teams map exclusivity across clinical, regulatory, and IP timelines.
  • Highlight proactive approaches to preventing or mitigating the patent cliff where relevant.
  • Discuss when the patent cliff may be less of a concern for advanced therapies and identify other risks and blind spots in exclusivity planning.

Speakers: